About Alcami
Alcami is a company based in Wilmington (United States) founded in 2016 was acquired by GHO Capital Partners in November 2022. Alcami has completed 3 acquisitions, including Alcami, Masy BioServices and Triangle Pharmaceuticals. Alcami offers products and services including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage. Alcami operates in a competitive market with competitors including Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others.
- Headquarter Wilmington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Alcami Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Madison Dearborn Partners
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Alcami
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alcami
Alcami offers a comprehensive portfolio of products and services, including Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Services for sterile fill-finish and oral solid dose production.
Testing for analytical and microbiological needs in pharma.
Secure cGMP storage with calibration and validation support.
People of Alcami
Unlock access to complete
Funding Insights of Alcami
Detailed funding history for Alcami
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Alcami
Alcami has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Madison Dearborn Partners, GHO Capital and The Vistria Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward key sectors by MDP.
|
Locked | Locked | Locked | |
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked | |
|
A private investment firm focused on essential industries is operated.
|
Locked | Locked | Locked |
Investor details for Alcami
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alcami
Alcami has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Alcami, Masy BioServices and Triangle Pharmaceuticals.
Investment portfolio details for Alcami
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-GMP and GMP pharmaceutical materials are managed across supply chains.
|
Locked | Locked | 2010 | Locked | |
|
Nucleoside analogs for HIV & Hepatitis-B
|
Locked | Locked | 1994 | Locked | |
|
Specializes in calibration, qualification and biostorage for life sciences
|
Locked | Locked | 1984 | Locked |
Complete acquisition details for Alcami
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Alcami
Detailed financials for Alcami
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alcami Comparisons
Peer comparison for Alcami
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alcami
Alcami operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Seqens, Asymchem, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
Contract research and development services for small molecules are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Detailed competitors of Alcami
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alcami
Complete news archive for Alcami
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alcami
Alcami was founded in 2016.
Alcami is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Stephan Kutzer is the current CEO of Alcami.
Alcami was established in 2016 through the merger of AAIPharma and Cambridge Major Laboratories. Small molecule development and manufacturing solutions are delivered to pharmaceutical companies in the outsourcing sector. Services encompass formulation, analytical and biopharmaceutical development, analytical testing, oral dose and parenteral manufacturing for final drug products, API manufacturing, as well as packaging and labelling. Operations are headquartered in Wilmington, United States.
Alcami's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Alcami offers Drug Product Manufacturing, Laboratory Services, and Pharmaceutical Storage.
Alcami has made 3 acquisitions, including Alcami, Masy BioServices, and Triangle Pharmaceuticals.
Alcami has 3 investors. Key investors include Madison Dearborn Partners, GHO Capital, and The Vistria Group.